4//SEC Filing
ROBINSON MATTHEW K 4
Accession 0001104659-23-070410
CIK 0001472012other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:57 PM ET
Size
5.3 KB
Accession
0001104659-23-070410
Insider Transaction Report
Form 4
Immunome Inc.IMNM
ROBINSON MATTHEW K
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+58,000→ 58,000 totalExercise: $4.84Exp: 2033-06-08→ Common Stock (58,000 underlying)
Footnotes (1)
- [F1]One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001934462
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:57 PM ET
- Size
- 5.3 KB